Chemodynamic therapy (CDT) that utilizes Fentontype reactions to convert endogenous hydrogen peroxide (H 2 O 2 ) into hydroxyl radicals ( • OH) is a promising strategy in anticancer treatment, but the overexpression of glutathione (GSH) and limited endogenous H 2 O 2 make the efficiency of CDT unsatisfactory. Here, an intelligent nanoplatform CuO 2 @mPDA/DOX-HA (CPPDH), which induced the depletion of GSH and the self-supply of H 2 O 2 , was proposed. When CPPDH entered tumor cells through the targeting effect of hyaluronic acid (HA), a release of Cu 2+ and produced H 2 O 2 were triggered by the acidic environment of lysosomes. Then, the Cu 2+ was reduced by GSH to Cu + , and the Cu + catalyzed H 2 O 2 to produce • OH. The generation of • OH could be distinctly enhanced by the GSH depletion and H 2 O 2 self-sufficiency. Besides, an outstanding photothermal therapy (PTT) effect could be stimulated by NIR irradiation on mesoporous polydopamine (mPDA). Meanwhile, mPDA was an excellent photoacoustic reagent, which could monitor the delivery of nanocomposite materials through photoacoustic (PA) imaging. Moreover, the successful delivery of doxorubicin (DOX) realized the integration of chemotherapy, PTT, and CDT. This strategy could solve the problem of insufficient CDT efficacy caused by the limited H 2 O 2 and overexpression of GSH. This multifunctional nanoplatform may open a broad path for self-boosting CDT and synergistic therapy.
Fe-based nanomaterials with Fenton reaction activity are promising for tumor-specific chemodynamic therapy (CDT). However, most of the nanomaterials suffer from low catalytic efficiency due to its insufficient active site exposure and the relatively high tumor intracellular pH, which greatly impede its clinical application. Herein, macrophage membranecamouflaged carbonic anhydrase IX inhibitor (CAI)-loaded hollow mesoporous ferric oxide (HMFe) nanocatalysts are designed to remodel the tumor microenvironment with decreased intracellular pH for selfamplified CDT. The HMFe not only serves as a Fenton agent with high active-atom exposure to enhance CDT but also provides hollow cavity for CAI loading. Meanwhile, the macrophage membrane-camouflaging endows the nanocatalysts with immune evading capability and improves tumoritropic accumulation by recognizing tumor endothelium and cancer cells through α4/VCAM-1 interaction. Once internalized by tumor cells, the CAI could be specifically released, which can not only inhibit CA IX to induce intracellular H + accumulation for accelerating the Fenton reaction but also could prevent tumor metastasis because of the insufficient H + formation outside cells for tumor extracellular matrix degradation. In addition, the HMFe can be employed to highly efficient magnetic resonance imaging to real-time monitor the agents' bio-distribution and treatment progress. Both in vitro and in vivo results well demonstrated that the nanocatalysts could realize self-amplified CDT and breast cancer metastasis inhibition via tumor microenvironment remodeling, which also provides a promising paradigm for improving CDT and antimetastatic treatment.
Therapeutic platforms with spatiotemporal
control were recently
of considerable interest. However, the site-specific regulation of
chemotherapeutics release remains an enormous challenge. Herein, a
versatile nanoplatform capable of tumor-specific delivery and controlled
drug release, coined as PDDFe, was constructed for elevating cancer
theranostics. Iron-oxide nanoparticles (IONPs) and doxorubicin (Dox)
were encapsulated in pH/thermal-sensitive micelles composed of poly(ethylene)glycol-poly(β-amino
esters) and dipalmitoyl phosphatidylcholine to obtain tumor-targeted
dual-responsive nanoplatforms. With remarkable magnetic targeting
effects, PDDFe specifically accumulated at tumor locations. After
internalization by cancer cells, the acidic environment and localized
heat generated by hyperthermia therapy would spur PDDFe to become
loose and collapse to liberate its payload. In addition to boosting
the release, the increased temperature also resulted in direct tumor
damage. Meanwhile, the released Dox and IONPs, respectively, stimulated
chemotherapy and chemodynamic therapy to jointly destroy cancer, thus
leading to a pronounced therapeutic effect. In vivo magnetic resonance/fluorescence/photoacoustic
imaging experiments validated that the dual-sensitive nanoplatforms
were able to accumulate at the tumor sites. Treatment with PDDFe followed
by alternating magnetic field and laser irradiation could prime hyperthermia/chemo/chemodynamic
therapy to effectively retard tumor growth. This work presents a nanoplatform
with a site-specific controlled release characteristic, showing great
promises in potentiating drug delivery and advancing combinational
cancer therapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.